IndraLab

Statements


CYLD deubiquitinates TRAF7. 1 / 2
1 | 1

reach
"CYLD deubiquitinates TRAF6 and TRAF7 to negatively regulate peptidoglycan-induced Toll-Like receptor 2 (TLR2) signaling and inflammation [45]."